SAKK4106_1: SAKK4106, figure 1

SAKK4106_1R Documentation

SAKK4106, figure 1

Description

Kaplan-Meier digitized data from SAKK4106, figure 1 (PMID 25605741). A reported sample size of 262 for a primary endpoint of TTP in colorectal cancer.

Usage

SAKK4106_1

Format

A data frame of 262 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (bev, no_bev)

Source

Koeberle D, Betticher DC, von Moos R, et al. Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Ann Oncol 2015; 26: 709–14.

Examples

summary(SAKK4106_1)

kmplot(SAKK4106_1)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.